BIO-plex magpix immunoassay system (bplx mgpx sys, BPM)
Ended Awarded
- Contract number
- HHSN26100012
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,500
Award facts
- Contract value 100% obligated
- $12,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division received a firm fixed-price Blanket Purchase Agreement (BPA) call from the National Cancer Institute for a Bio-Plex MagPix Immunoassay System valued at $12,500. The award was issued on March 25, 2014, with completion targeted for May 26, 2014, and performance occurring in Bethesda, Maryland. This contract was not designated as a small business set-aside, reflecting Bio-Rad's established position as a large federal contractor specializing in advanced laboratory instrumentation and diagnostics. The Bio-Plex MagPix system represents the company's sophisticated multiplex immunoassay platform technology, which enables simultaneous detection of multiple biomarkers—a critical capability for cancer research and clinical diagnostic applications.
This BPA call demonstrates Bio-Rad's role as a key supplier to the National Institutes of Health enterprise, providing specialized scientific equipment essential to the National Cancer Institute's research mission. Bio-Rad maintains a significant $10 million BPA with the NIH Office of Logistics and Acquisition Operations through December 31, 2025, which serves as the underlying vehicle for this and similar procurement activities. The company's extensive federal contracting history across multiple NIH institutes, the Centers for Disease Control and Prevention, the Food and Drug Administration, and the Department of Veterans Affairs underscores its critical role in supporting government research infrastructure and diagnostic capabilities across the life sciences sector.
Quick answers
Who was awarded contract HHSN26100012?
HHSN26100012 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on March 25, 2014.
How much is contract HHSN26100012 worth?
The government has obligated $12,500 on HHSN26100012.
Is contract HHSN26100012 an order under another contract?
Yes. HHSN26100012 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100012 competed?
The extent of competition for HHSN26100012 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award